Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM)
- First Posted Date
- 2011-06-30
- Last Posted Date
- 2012-08-17
- Lead Sponsor
- Prosidion Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT01386099
- Locations
- 🇿🇦
Synexus Clinical Research SA (Pty) Ltd, Pretoria, Gauteng, South Africa
🇿🇦Parexel Bloemfontein, Bloemfontein, South Africa
🇿🇦Parexel George, George, South Africa
News
No news found